TXN Quantitative Stock Analysis

Validea's guru fundamental report on Texas Instruments (TXN) indicates a 77% rating using Partha Mohanram's P/B Growth Investor model, which targets low book-to-market stocks with sustained growth potential. While TXN, a large-cap semiconductor stock, passed most fundamental tests including return on assets and cash flow, it notably failed on advertising and research and development to assets. This places TXN just below the 80% threshold typically signifying 'some interest' for this academically-derived, outperforming growth strategy.

Analysis

According to Validea's guru fundamental report, Texas Instruments (TXN) scores a 77% on the Partha Mohanram P/B Growth Investor model, positioning it just below the 80% threshold that typically indicates strategic interest. The analysis highlights a dichotomy in the company's profile: on one hand, TXN demonstrates robust financial health, passing criteria for Return on Assets, Cash Flow from Operations to Assets, and stability in both ROA and sales variance. These factors suggest strong current profitability and operational efficiency. On the other hand, the model flagged significant failures in two key growth-related investment areas: the ratios of Advertising to Assets and, more critically, Research and Development (R&D) to Assets. For a large-cap firm in the highly competitive semiconductor industry, the failure on the R&D metric is a material concern, potentially signaling a risk to its long-term innovation pipeline and competitive positioning, despite its present fundamental strength.

Key Decisions for Investors

• Investors should weigh TXN's strong current profitability and cash flow metrics against the potential long-term risk highlighted by its failure to meet the model's R&D-to-assets threshold.
• Growth-focused investors who follow the Mohanram model may remain on the sidelines, as the 77% score does not meet the 80% 'interest' level, suggesting other opportunities may offer a better fit for this specific strategy.
• It is now critical to monitor TXN's quarterly R&D expenditures as a percentage of assets and revenue to assess whether the company is allocating sufficient capital to sustain its technological edge.